Clinical trial
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
NCT00256243 · Rita Sanghvi, Mehta, Other · Completed
Key facts
| NCT number | NCT00256243 |
|---|---|
| Title | Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer |
| Official title | A Pilot Study of Neoadjuvant Biweekly Doxorubicin and Cyclophosphamide (AC) With GMCSF Followed by Weekly Carboplatin/Paclitaxel With Plus or Minus Trastuzumab (TC ± H) in the Treatment of Breast Cancer |
| Lead sponsor | Rita Sanghvi, Mehta, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Doxorubicin, Cyclophosphamide, Paclitaxel, Carboplatin, GM-CSF, Trastuzumab |
| Enrollment | 48 |
| Start date | Apr 1, 2004 |
| Primary completion | Mar 1, 2011 |
| Completion | Jul 1, 2012 |
| First posted | Nov 21, 2005 |
| Last update posted | Mar 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: